Compare AFL & CCEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFL | CCEP |
|---|---|---|
| Founded | 1955 | 1986 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Beverages (Production/Distribution) |
| Sector | Finance | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.8B | 44.9B |
| IPO Year | 1994 | 2015 |
| Metric | AFL | CCEP |
|---|---|---|
| Price | $113.83 | $96.64 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $110.18 | $105.83 |
| AVG Volume (30 Days) | ★ 2.0M | 1.9M |
| Earning Date | 04-29-2026 | 02-17-2026 |
| Dividend Yield | 2.16% | ★ 2.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.82 | N/A |
| Revenue | ★ $17,164,000,000.00 | N/A |
| Revenue This Year | N/A | $4.76 |
| Revenue Next Year | $1.61 | $3.82 |
| P/E Ratio | ★ $16.58 | $20.93 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $96.95 | $84.66 |
| 52 Week High | $119.32 | $110.90 |
| Indicator | AFL | CCEP |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 52.25 |
| Support Level | $106.07 | $89.03 |
| Resistance Level | $115.84 | $99.88 |
| Average True Range (ATR) | 2.08 | 1.96 |
| MACD | 0.54 | 0.61 |
| Stochastic Oscillator | 97.75 | 74.84 |
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments: Aflac Japan, which generates the maximum revenue, and Aflac U.S.
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia. In 2025, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume.TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.